Details for 2018150826

Up to date per 01.04.2026

Actions

Title / Product Name

INJIZIERBARE BOTULINUMTOXINFORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018150826

EP Publication Number

3332805

E-Number

1469924

Language

PCT Number

Publication Date

13.06.2018 A

23.02.2022 B1

Registration Date

23.02.2022

AT Publication Date

15.03.2022

Application Date

28.12.2009

Registration Number

Priorities

31.12.2008

142063 P

IPC

A61K 39/08 20060101AFI20180313BHEP

Maximum Duration of Protection

28.12.2029

Owner

ReVance Therapeutics, Inc.7555 Gateway Blvd. Newark, CA 94560US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

RUEGG, Curtis, L.826 Shepard Way Redwood City, CA California 94062US

STONE, Hongran, F.1799 Croner Ave. Menlo Park, CA California 94025US

WAUGH, Jacob, M.425 First Street, 1801 San Francisco, CA California 94105US

Information about Fees